The secretary of biotechnology development headquarter stated: general acceptance and commercialization of products with a biological basis will face many problems if there is no clear standardization and coherent and prosecute labeling.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Mostafa Ghanei, secretary of biotechnology development headquarter, expressed about the necessity of standardization of biological products: biotechnology is one of the prioritized areas, investment and innovation in which must be taken into account.

He continued: lack of relevant standardization is identified as a barrier to the selling of products with a biological basis.

According to Ghanei, standards help increase the clarity in the market, which leads to elevated use of products with a biological basis.

He also marked: this will also lead to increased trust of customers in use of products with biological basis.